BR112012033625A2 - método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico - Google Patents

método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico

Info

Publication number
BR112012033625A2
BR112012033625A2 BR112012033625A BR112012033625A BR112012033625A2 BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2 BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A BR112012033625 A BR 112012033625A BR 112012033625 A2 BR112012033625 A2 BR 112012033625A2
Authority
BR
Brazil
Prior art keywords
bound
protein
uremic toxins
determining
content
Prior art date
Application number
BR112012033625A
Other languages
English (en)
Portuguese (pt)
Inventor
Fredrik Uhlin
Ivo Fridolin
Jana Jerotskaja
Jürgen Arund
Risto Tanner
Original Assignee
Univ Tallinn Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EEP201000056A external-priority patent/EE05676B1/xx
Priority claimed from EEP201000085A external-priority patent/EE05669B1/xx
Application filed by Univ Tallinn Technology filed Critical Univ Tallinn Technology
Publication of BR112012033625A2 publication Critical patent/BR112012033625A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • External Artificial Organs (AREA)
BR112012033625A 2010-06-28 2011-06-28 método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico BR112012033625A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EEP201000056A EE05676B1 (et) 2010-06-28 2010-06-28 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
EEP201000085A EE05669B1 (et) 2010-12-10 2010-12-10 Optiline meetod ja seade keskmise suurusega ja valkudega seotud ureemiliste toksiinide m„„ramiseks bioloogilistes vedelikes
PCT/EE2011/000008 WO2012000521A1 (en) 2010-06-28 2011-06-28 A method and device for determining content of the middle and protein bound uremic toxins in a biological fluid

Publications (1)

Publication Number Publication Date
BR112012033625A2 true BR112012033625A2 (pt) 2016-10-25

Family

ID=44508544

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033625A BR112012033625A2 (pt) 2010-06-28 2011-06-28 método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico

Country Status (10)

Country Link
US (1) US9103789B2 (enExample)
EP (1) EP2585830B1 (enExample)
JP (1) JP5957450B2 (enExample)
KR (1) KR101848527B1 (enExample)
CN (1) CN102985822A (enExample)
AU (1) AU2011274009B2 (enExample)
BR (1) BR112012033625A2 (enExample)
CA (1) CA2837488C (enExample)
NZ (1) NZ605685A (enExample)
WO (1) WO2012000521A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112790A1 (de) * 2012-12-20 2014-06-26 B. Braun Avitum Ag Verfahren und Vorrichtung zur Bestimmung von Abfallprodukten wie Indoxyl Sulfate in der Dialyse
US10150983B2 (en) * 2013-02-19 2018-12-11 Nipro Corporation Method for measuring indoxyl sulfuric acid
CN104991026A (zh) * 2015-06-29 2015-10-21 苏州东辰林达检测技术有限公司 尿液中甲基马尿酸的检测方法
EP3537135A1 (en) * 2018-03-05 2019-09-11 Tallinn University of Technology A device and method for assessment of a concentration of free pentosidine in a spent dialysate
JP7207702B2 (ja) * 2018-11-06 2023-01-18 国立研究開発法人農業・食品産業技術総合研究機構 成分抽出方法、蛍光指紋測定装置、及びコンピュータが実行可能なプログラム
GB202104698D0 (en) * 2021-03-31 2021-05-12 Tallinn Univ Of Technology Multiparametric optical method and apparatus for the determination of uremic solutes, including uremic toxins, in biological fluids
TWI838830B (zh) * 2022-04-08 2024-04-11 財團法人工業技術研究院 β2-微球蛋白濃度的分析方法及裝置
CN120948421A (zh) * 2025-10-15 2025-11-14 天津医科大学 一种定量-判别一体化尿毒症智能检测系统

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3261264B2 (ja) 1994-07-13 2002-02-25 株式会社堀場製作所 多成分水溶液の分析方法およびその分析装置
WO1998019592A1 (en) * 1996-11-01 1998-05-14 Rio Grande Medical Technologies, Inc. Dialysis monitoring method and apparatus
US6261848B1 (en) * 1998-05-08 2001-07-17 The Johns Hopkins University Miniature immuno-optical rapid analyte sensor platform
SE525639C2 (sv) 1998-06-04 2005-03-22 Thore Falkvall Bestämning av slaggprodukter i dialysvätska med hjälp av optisk sensor
AUPR748501A0 (en) * 2001-09-04 2001-09-27 Life Therapeutics Limited Renal dialysis
US8337444B2 (en) * 2001-05-22 2012-12-25 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Measurement of cardiac output and blood volume by non-invasive detection of indicator dilution for hemodialysis
RU2212029C1 (ru) 2001-12-03 2003-09-10 Общество с ограниченной ответственностью "Клиника экстракорпоральной гемокоррекции" Способ анализа жидкой биологической среды в процессе мониторинга
US7002670B2 (en) * 2002-06-12 2006-02-21 Baxter International Inc. Optical sensor and method for measuring concentration of a chemical constituent using its intrinsic optical absorbance
EP1643240A4 (en) * 2003-07-03 2010-09-22 Wako Pure Chem Ind Ltd METHOD FOR MEASURING CERTAIN COMPONENTS BY MEANS OF SPECTRAL MEASUREMENT
US7427508B2 (en) 2003-10-09 2008-09-23 Organotek Defense System Corporation Method for assaying multi-component mixtures
WO2005069737A2 (en) * 2004-01-27 2005-08-04 Ramot At Tel Aviv University Ltd. Method and system for detecting analytes
EP1751523B1 (en) 2004-05-13 2017-10-04 NarTest AS A portable device and method for on-site detection and quantification of drugs
US7966051B2 (en) * 2005-01-11 2011-06-21 Olympus Corporation Fluorescent agent concentration measuring apparatus, dose control apparatus, administration system, fluorescent agent concentration measuring method, and dose control method
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
WO2009071102A1 (en) 2007-12-04 2009-06-11 Tallinn University Of Technology Optical method and device for measuring concentrations of substances in biological fluids

Also Published As

Publication number Publication date
AU2011274009B2 (en) 2016-06-23
WO2012000521A1 (en) 2012-01-05
EP2585830A1 (en) 2013-05-01
EP2585830B1 (en) 2018-04-25
US20130193347A1 (en) 2013-08-01
CA2837488A1 (en) 2012-01-05
CN102985822A (zh) 2013-03-20
JP2013534630A (ja) 2013-09-05
US9103789B2 (en) 2015-08-11
KR101848527B1 (ko) 2018-04-12
NZ605685A (en) 2014-10-31
AU2011274009A1 (en) 2013-01-31
JP5957450B2 (ja) 2016-07-27
KR20130038347A (ko) 2013-04-17
CA2837488C (en) 2021-10-26

Similar Documents

Publication Publication Date Title
BR112012033625A2 (pt) método e dispositivo para determinação do conteúdo das toxinas urêmicas ligadas na proteína e intermediárias em um fluido biológico
BRPI0916624A2 (pt) anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
BR112013021963A2 (pt) sistema e método de separação de sangue para uma tira de teste seca
BRPI1007321A2 (pt) métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo.
MX2012000388A (es) Prueba de equilibrio peritoneal simplificada para dialisis peritoneal.
BR112014031407A2 (pt) método e dispositivo para a monitoração de um tratamento de sangue extracorpóreo de um paciente
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
DK2413142T3 (da) Fremgangsmåde til forudsigelse af NSCLC-patienters reaktion på behandling med en EGFR-TK-inhibitor
BR112012026361A2 (pt) previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar
BR112014003877A2 (pt) biomarcadores de micro-rna e métodos de uso dos mesmos
BR112014010067A8 (pt) método e sistema para usar disparos de rastreador para estimar volumes de influxo de fluidos a partir de diferentes zonas de influxo para um fluxo de produção em um poço
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
BR112013004254A2 (pt) conjunto, método, sistema, e aparelho para avaliação do nível de partículas de lipoproteína específicas presentes em um fluido corporal
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
CY1117838T1 (el) Παραγοντες προβλεψης για θεραπευτικη αγωγη καρκινου
BRPI0505096B8 (pt) processo de separação por eletroforese capilar em solução livre (fsce) das hemoglobinas em amostras biológicas, utilização de um redutor de fluxo escolhido dentre diaminas alifáticas, poliaminas alifáticas, e seus derivados e sais aceitáveis, e suas misturas, e, kit de análise da hemoglobina para realizar o processo de separação das hemoglobinas em amostras biológicas por eletroforese capilar em solução livre (fsce)
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
RU2015108014A (ru) Системы и способы минимально инвазивного измерения газов в артериальной крови
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
BR112013020241A2 (pt) métodos de análise de placa
EP2505667A3 (en) Device and method for analysis of kidney failure
BR112021017144A2 (pt) Ensaio para detectar uma proteína associada à membrana, métodos para quantificar a concentração de proteína circulante, para determinar se um paciente com linfoma de células b tem probabilidade de exibir uma resposta a uma terapia anti-cd20, para determinar a afinidade de um anticorpo anti-cd20, para determinar a ativação de células t e método de tratamento de um tumor
Salmaso Rationale and application of high throughput sequencing approaches in the study of biodiversity and water quality assessment

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: OUE OPTOFLUID TECHNOLOGIES (EE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements